A new male contraceptive, RISUG (Reversible Inhibition of Sperm Under Guidance) is undergoing a clinical trial in India. American men are eagerly awaiting the results of this large clinical trial.
It is a reversible, non-hormonal contraceptive to provide 10 or more years of protection after a 10-15 minute procedure. After a delay of nearly four years, it is ultimately this week; researchers received approval to begin enrolling additional study volunteers.
In the RISUG study, doctors inject a gel into the tube that sperm travel through after they are produced (known as the vas deferens). The gel then disables the sperm as they swim by. In study animals, male fertility returns if the RISUG is flushed out with another injection that dissolves the gel.
Via: Biology News